Functional Technologies Corp. reports that efficacy studies conducted on end-user materials, investigating the Company's proprietary acrylamide-preventing (AP) yeast technology in a novel food application that traditionally does not incorporate yeast i...

Functional Technologies Corp. is pleased to report the development of a third (3rd) generation of its proprietary acrylamide-preventing (AP) yeast platform, wherein various improvements made to the Company's original underlying AP technology have enabl...

Functional Technologies Corp. (TSX-V: FEB) is pleased to announce that its subsidiary, Phyterra Yeast Inc., has been awarded $2.5 million from the Government of Canada's Atlantic Innovation Fund

Funcional Technologies Corp. (TSX-V: FEB) se complace en anunciar que su filial, Phyterra Yeast Inc. ha sido beneficiada con 2,5 millones de dólares del Fondo de Inversión del Canada (AIF). El proyecto desarrollará y comercializará una tecnología par...

Functional Technologies Corp (TSX-V: FEB), a world leader in yeast research and development, today announced initial test results for bread made with its acrylamide-preventing yeast demonstrated reductions of acrylamide of approximately 90%.